LY-338979
| Code | Size | Price |
|---|
| TAR-T20355-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
LY-338979 is a chemical compound.
CAS:
193281-00-4
Formula:
C20H21N5O7
Molecular Weight:
443.416
Purity:
0.98
SMILES:
Nc1nc(=O)c2C(CCc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C(=O)Nc2[nH]1
References
1. Ardenne M, Reitnauer PG. [Tumour hyperacidulation through intravenous glucose infusion enhanced by amygdalin and beta-glucosidase application (author's transl)]. Arch Geschwulstforsch. 1975;45(2):135-45. German. PubMed PMID: 979.